BARDINA, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.785
EU - Europa 1.072
AS - Asia 338
AF - Africa 40
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 3.267
Nazione #
US - Stati Uniti d'America 1.766
IT - Italia 219
CN - Cina 185
DE - Germania 167
SE - Svezia 134
IE - Irlanda 126
UA - Ucraina 81
FR - Francia 69
DK - Danimarca 57
FI - Finlandia 49
VN - Vietnam 49
GB - Regno Unito 43
BE - Belgio 33
SN - Senegal 32
IN - India 26
KR - Corea 23
PL - Polonia 20
GR - Grecia 16
CA - Canada 15
ES - Italia 14
AT - Austria 11
JP - Giappone 11
NL - Olanda 11
TR - Turchia 11
IL - Israele 10
EU - Europa 7
IR - Iran 7
CO - Colombia 6
BR - Brasile 5
NO - Norvegia 5
MU - Mauritius 4
MX - Messico 4
NZ - Nuova Zelanda 4
SG - Singapore 4
UZ - Uzbekistan 4
AU - Australia 3
CZ - Repubblica Ceca 3
HK - Hong Kong 3
RO - Romania 3
ZA - Sudafrica 3
BG - Bulgaria 2
CH - Svizzera 2
EC - Ecuador 2
ID - Indonesia 2
RU - Federazione Russa 2
UY - Uruguay 2
A1 - Anonimo 1
AR - Argentina 1
CL - Cile 1
DZ - Algeria 1
HR - Croazia 1
HU - Ungheria 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
NP - Nepal 1
PK - Pakistan 1
PT - Portogallo 1
Totale 3.267
Città #
Chandler 319
Ann Arbor 192
Fremont 140
Beijing 129
Dublin 122
Fairfield 92
Torino 81
Houston 62
Wilmington 55
Dearborn 53
Nyköping 52
Woodbridge 50
Dong Ket 47
Medford 42
Villeurbanne 42
Jacksonville 40
Redwood City 37
Ashburn 36
Princeton 36
Seattle 32
Cambridge 30
Brussels 27
Pisa 20
Turin 20
Warsaw 18
Washington 15
Milan 14
Boardman 11
Vienna 11
San Diego 10
Boston 9
Guangzhou 9
Hangzhou 8
Mountain View 8
Toronto 8
Düsseldorf 7
Menlo Park 7
Nanjing 7
Norwalk 7
Coventry 6
Duncan 6
Kunming 6
Hefei 5
Rome 5
Stavanger 5
Dallas 4
Hanover 4
Heidelberg 4
Kharkiv 4
Leawood 4
Madrid 4
Netanya 4
Oldenburg 4
Tokyo 4
Amsterdam 3
Cork 3
Gazi 3
Istanbul 3
Jinan 3
Johannesburg 3
New York 3
Nürnberg 3
Palermo 3
Paris 3
San Mateo 3
Sevilla 3
Auckland 2
Central District 2
Coimbatore 2
Glen Mills 2
Guayaquil 2
Hasselt 2
Hebei 2
Helsinki 2
Jerusalem 2
Leiden 2
London 2
Magelang 2
Montevideo 2
Montreal 2
Munich 2
Naples 2
Niagara Falls 2
Phoenix 2
Prague 2
Redmond 2
Saluzzo 2
Southend 2
Sydenham 2
Tepotzotlán 2
Tur`an 2
Villabona 2
Wayne 2
West Chicago 2
Zagarolo 2
Addlestone 1
Alessandria 1
Ankara 1
Arvada 1
Barcelona 1
Totale 2.073
Nome #
Pregnancy epigenetic signature in T helper 17 and T regulatory cells in multiple sclerosis 367
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis 251
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months 173
Alemtuzumab Long Term Immunological Study: The Immunosuppressive Effect Does Not Last More Than 48 Months 162
In Human Multiple sclerosis, T helper 17 lymphocytes display increased levels of JAK2 that stabilize cell surface IFN-YR2chain 142
T helper subsets changes in alemtuzumab multiple sclerosis treated patients: the recovery of immune system capacity as a possible indicator to treatment 135
Lack of CD4 + T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses 130
A new T helper subset producing Interleukin 22 increases in multiplesclerosis patients. 128
Natalizumab in Multiple Sclerosis: Long-Term Management 123
Alterations in gut microbiome are associated with the onset of multiple sclerosis: an Italian pivotal study 122
How do Treg cell function and related cytokines levels change in alemtuzumab treated patients? A 24 months immunological study 110
The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice 90
THE ACUTE-PHASE PROTEIN HEMOPEXIN IS A NEGATIVE REGULATOR OF TH17 RESPONSE AND EXPERIMENTAL AUTOIMMUNE ENCEPHALOMIELITIS DEVELOPMENT 89
Circulating T helper 22 cells increase in multiple sclerosis patients:phenotypical and functional characterization. 82
Treg Cell Function and Related Cytokines and Chemokines Changes during Alemtuzumab Treatment: a 24 Months Immunological Study 81
Alemtuzumab treatment in MS how do the Treg cell function and suppressor cytokine mRNA (IL-10, TGF-beta, IL_27) levels change? 24-month immunological report during 323 and 324 genzyme trials 80
T HELPER 22 CELLS INCREASE IN MULTIPLE SCELROSIS PATIENTS: PHENOTYPICAL AND FUNCTIONAL CHARACTERIZATION 75
Gut microbiota alteration in Clinically Isolated Syndrome: a pilot study 75
T HELPER 22 CELLS INCREASE IN MULTIPLE SCLEROSIS PATIENTS: PHENOTYPICAL AND FUNCTIONAL CHARACTERIZATION 73
T Regulatories (Tregs) and suppressor cytokine mRNA (IL-10, TGF-beta, IL-27) increase after Alemtuzumab in MS: First 25 Month Immunological Report on 323 and 324 Genzyme trials 73
Alemtuzumab long-lasting immunological effects: a 48 months follow-up observation 73
Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity 72
Long Term immunological alemtuzumab effect: increase in Tregsuppressor function 70
Epigenetic mechanisms regulate T helper 17 and T regulatory cells during pregnancy in multiple sclerosis. 68
Epigenetic signature in T helper 17 and regulatory T cells in multiple sclerosis patients during pregnancy 66
Chromatin remodeling in Th17 and Treg plasticity induced by E2 immunomodulation 63
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-  60
How to treat patients after natalizumab discontinuation: the TY-STOP 2 study, an Italian, prospective and multicenter study 56
T helper 22 increase in multiple sclerosis patints: phenotypical and functional characterization 53
Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up 52
Phenotypical and functional characterization of T Helper 22 cells inMultiple Sclerosis patients 42
Gut microbiota and metagenomic diversity in Clinical Isolated Syndrome 42
Role of Th22 expansion in multiple sclerosis disease activity 39
Six year prospective immunological study of alemtuzumab treated patients: identification of markers of the clinical response 38
Multiparametric analysis of Th17 and Th22 cells discloses their pathogenicity in human multiple sclerosis 37
Totale 3.392
Categoria #
all - tutte 6.711
article - articoli 0
book - libri 0
conference - conferenze 3.923
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.634


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019149 0 0 10 1 4 7 2 22 7 31 34 31
2019/2020471 14 18 27 53 23 82 48 36 38 63 34 35
2020/2021573 41 41 18 85 50 46 49 27 57 37 55 67
2021/2022571 18 19 19 34 36 42 31 40 25 84 120 103
2022/2023826 63 70 27 101 74 182 53 67 96 31 43 19
2023/2024129 58 49 22 0 0 0 0 0 0 0 0 0
Totale 3.392